Oncoproteomics: Towards Personalized Precision Medicine
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Proteins and Proteomics".
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 3400
Special Issue Editors
Interests: colorectal cancer; proteomics; mass spectrometry; antibody; plasma biomarker; proteins; cancer patient survival; tumor recurrence/relapse; mold biotoxin; chronic inflammatory response syndrome (CIRS)
Special Issues, Collections and Topics in MDPI journals
Interests: colorectal cancer; proteomics; mass spectrometry; antibody; plasma biomarker; proteins; cancer patient survival; tumor recurrence/relapse; mold biotoxin; chronic inflammatory response syndrome (CIRS)
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Proteomics technology in the last decade has exponentially improved, leading to it now been seen as a viable contender or at least complimentary to genomics. Its contribution to medicine and specifically oncology has perhaps been the most exciting with the ability now to discern with great accuracy distinguishing molecular characteristics of individuals leading to a hint of true personalized medicine. This is especially true in cancer therapeutics where the recent boon in immunotherapy has had a noticeable effect on survival rates of various cancers. With this special issue we wish to highlight the role proteomics has had on the development of personalized precision medicine in cancer specifically.
The issue will cover topics such as developments in DIA/SWATH in diagnosis of cancer, progress in using proteomics for tissue typing and early diagnosis, the use of AI and novel bioinformatics methodologies in decerning individual patient data and predicting success of therapeutics and more. We welcome suggestions and topical research papers and reviews to highlight progress in this area of proteomics.
Dr. Abidali Mohamedali
Dr. Seong Beom Ahn
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oncoprotomics
- mass spectrometry
- DIA/SWATH
- early diagnosis
- immunotherapy
- cancer proteomics
- precision medicine
- personalized medicine
